Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/12113
Title: An in vitro model to investigate the interactions between antimicrobial peptides and the outer membrane of gram-negative pathogens
Authors: Han, ML
Shen, HH
Zhu, Y
Le Brun, AP
Holt, SA
Roberts, K
Song, JN
Cooper, MA
Moskowitz, SM
Velkov, T
Li, J
Keywords: Antibiotics
Bacteria
Antimicrobial agents
Lipids
Peptides
Drugs
Issue Date: 29-Nov-2016
Publisher: Australian Institute of Nuclear Science and Engineering
Citation: Han, M.-L., Shen, H.-H., Zhu, Y., Le Brun, A. P., Holt, S. A., Roberts, K., Song, J.-N., Cooper, M. A., Moskowitz, S. M., Velkov, T., & Li, J. (2016). An in vitro model to investigate the interactions between antimicrobial peptides and the outer membrane of gram-negative pathogens. Paper presented at 13th AINSE-ANBUG Neutron Scattering Symposium, Sydney, NSW, Australia, 29-30 November 2016.
Abstract: Increasing antibiotic resistance in Gram-negative bacteria led to polymyxins as the last therapy. Polymyxins present their antimicrobial activity through an initial electronical interaction with lipid A in the outer membrane (OM) of GNB, and the most common mechanism of polymyxin resistance is through modifications of lipid A with positively charged groups, such as 4-amino-L-arabinose (L-Aar4N) or phosphoethanolamine (pEtN). However, it is notable that Gram-negative bacteria employ a combination of charge-charge repulsion mechanism and the modification to fatty acyl chains of lipid A to obtain high-level polymyxin resistance. Hence, we designed hydrophobic polymyxin-related lipopeptides in order to overcome modified lipid A to insert into the outer membrane of Gram-negative bacteria. In this study, we employed neutron reflectometry (NR) study to investigate the interactions between lipid A and polymyxins. Lipid A was extracted from polymyxin-susceptible and -resistant pseudomonas aeruginosa strains, and analysed using ESI-MS in the negative ion mode. The asymmetric lipid A: deuterated DPPC bilayers were deposited on SiO2 surfaces by combined Langmuir-Blodgett and Langmuir-Schaefer disposition methods, and characterised by neutron reflectometer. Our results showed L-Ara4N modified lipid A was observed in polymyxin-resistant PAKpmrB6 strain, but not in the wild-type PAK strain. The NR data obtained from unmodified lipid A: DPPC bilayer was fitted into a five-layer model. Whereas, a six-layer model containing an extra outer headgroup was established for L-Ara4N modified lipid A: d-DPPC bilayer. Our results showed a dense of PMB (volume fraction of >20%) bound to the surface of both unmodified and modified lipid A: DPPC bilayers. While it is notable that the significant changes in NR profiles obtained from H2O contrast indicated about 15.8% and 6.1% of PMB penetrated into the wild-type lipid A headgroup and fatty acyl chains, respectively, but without penetration into L-Ara4N-lipid A: d-DPPC bilayer. However, the employment of octpeptin A3 induced higher hydrophobic interactions with L-Ara4N-lipid A: d-DPPC bilayer. Our study provides an in vitro model to investigate the interactions of polymyxins with OM bilayers in GNB, and confirmed that lipid A modification with L-Ara4N was certainly to reduce the penetration of PMB into bacterial membranes. Remarkably, the higher binding affinity between octapeptin A3 and L-Ara4N modified lipid A indicated its potential to be the new generation antibiotics for the therapy of infections caused by multi-drug resistant Gram negative bacteria.
URI: https://apo.ansto.gov.au/dspace/handle/10238/12113
Appears in Collections:Conference Publications

Files in This Item:
File Description SizeFormat 
Abstract_Handbook_v2(1).pdf1.92 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.